hypertension
AstraZeneca bolts on blood pressure drug with CinCor takeover
Phil Taylor
AstraZeneca, cardiovascular, chronic kidney disease, CinCor Pharma, Farxiga, hypertension, M&A, nephrology
0 Comment
Idorsia files resistant hypertension drug aprocitentan in US
Phil Taylor
aprocitentan, cardiovascular disease, hypertension, Idorsia, Johnson & Johnson, regulatory
0 Comment
J&J, Idorsia plan filings for aprocitentan data in resistant hypertension
Phil Taylor
aprocitentan, cardiovascular disease, hypertension, Idorsia, Janssen, Johnson & Johnson
0 Comment
George taps Medisante tech for decentralised blood pressure trial
Phil Taylor
decentralised clinical trials, digital, digital health, George Medicines, hypertension, Medisante
0 Comment
MHRA gives Alnylam ‘innovation passport’ for hypertension drug zilebesiran
Phil Taylor
Alnylam, HEOR, hypertension, innovation passport, MHRA, NHS, regulatory, UK, zilebesiran
0 Comment
CLM tests drug plus digital combo for high blood pressure
Phil Taylor
app, Closed Loop Medicine, digital, hypertension
0 Comment
Celltrion buys drug portfolio from Takeda, ventures into chronic diseases
Richard Staines
Celltrion, chronic diseases, Diabetes, hypertension, M&A, Takeda
0 Comment
AZ picks up $350m after selling hypertension drugs
Richard Staines
AstraZeneca, Bayer, cancer, cardiology, GW Pharma, hypertension, multiple sclerosis
0 Comment